| | Business Summary | | eResearchTechnology,
Inc.,
formerly
known
as
PRWW,
Ltd.,
is
a
business-to-business
provider
of
integrated
software
applications
and
technology
infrastructure
to
the
pharmaceutical,
biotechnology
and
medical
device
industries.
The
Company
offers
Internet
and
other
technology-based
solutions
designed
to
streamline
the
clinical
trials
process
through
the
automation
of
many
parts
of
a
clinical
trial.
The
Company
is
also
a
provider
of
centralized
collection
and
interpretation
of
electrocardiograms,
one
of
the
most
frequently
used
tests
in
clinical
trials.
The
Company's
solutions
are
designed
to
improve
the
accuracy,
timeliness
and
efficiency
of
trial
set-up,
data
collection,
management
and
interpretation
and
new
drug
or
device
application
preparation. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | ERES
develops,
markets
and
supports
clinical
trial
and
data
management
software
and
consulting
services.
ERES
also
provides
centralized
diagnostic
testing
services.
For
the
six
months
ended
6/30/01,
total
revenues
fell
2%
to
$12.9
million.
Net
loss
totaled
$5.4
million,
up
from
$165
thousand.
Revenues
reflect
a
delay
in
license
contract
signings.
Net
loss
reflects
a
$5
million
charge
related
to
continued
negative
market
conditions
of
the
investments
in
Medical
Advisory
Systems,
Inc. | | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Joel Morganroth, M.D., 54
Chairman
and Chief Scientist | $441K | Joseph Esposito, 47
Pres,
CEO, Director | 452K | Bruce Johnson, 49
CFO,
Sr. VP | -- | David Dworaczyk, Ph.D., 43
Sr.
VP- Bus. Devel. | 176K | John Bauer, 51
VP | -- | | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/e/eres.gif)